Development of the Brief Bedside Dysphagia Screening Test – Revised: a Cross-Sectional Czech Study

Mandysová, Petra; Ehler, Edvard; Škvrňáková, Jana; Černý, Michal; Bártová, Iva; Pellant, Arnošt

doi:10.14712/18059694.2015.93

Acta Medica > Archive > 2015, Vol. 58 > Issue 2 > Development of the Brief Bedside…

Acta Med. 2015, 58: 49-55

https://doi.org/10.14712/18059694.2015.93

Development of the Brief Bedside Dysphagia Screening Test – Revised: a Cross-Sectional Czech Study

Petra Mandysová^a,b, Edvard Ehler^a,b, Jana Škvrňáková^b,c, Michal Černý^d, Iva Bártová^c, Arnošt Pellant^b,c

^aDepartment of Neurology, Pardubice Hospital, Hospitals of the Pardubice Region, Czech Republic
^bFaculty of Health Studies, University of Pardubice, Czech Republic
^cDepartment of Otorhinolaryngology and Head and Neck Surgery, Pardubice Hospital, Hospitals of the Pardubice Region, Czech Republic
^dDepartment of Otorhinolaryngology and Head and Neck Surgery, University Hospital Hradec Králové, Charles University in Prague, Faculty of Medicine in Hradec Králové, Czech Republic

Received March 24, 2015
Accepted May 11, 2015

Aim: The purpose of this study was to develop a revised version of the Brief Bedside Dysphagia Screening Test for determining penetration/aspiration risk in patients prone to dysphagia. The priority was to achieve high sensitivity and negative predictive value. Methods: The study screeners conducted bedside assessment of the swallowing function in 157 patients with a neurological (mainly stroke) or an ear, nose, and throat diagnosis (mainly head and neck cancer). The results were compared with a gold standard, flexible endoscopic examination of swallowing. Results: For the neurological subgroup (N = 106), eight statistically significant bedside assessment items were combined into the Brief Bedside Dysphagia Screening Test-Revised (BBDST-R). Cut-off score 1 produced the highest sensitivity (95.5%; 95% confidence interval CI [CI]: 84.9–98.7%) and negative predictive value (88.9%; 95% CI 67.2–96.9%). Conclusion: The BBDST-R is suitable for dysphagia screening in departments caring for patients with neurological conditions.